Journal
JOURNAL OF RHEUMATOLOGY
Volume 36, Issue 8, Pages 1575-1579Publisher
J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.081321
Keywords
ANTI-TUMOR NECROSIS FACTOR-alpha; INFLIXIMAB; OSTEOBLASTS; INTERLEUKIN 1 beta; INTERLEUKIN 6; OSTEOPROTEGERIN
Categories
Ask authors/readers for more resources
Objective. Tumor necrosis factor-alpha (TNF-alpha) is a proinflammatory cytokine involved in the pathogenesis of several rheumatic diseases, including rheumatoid arthritis (RA), associated with systemic bone loss and subchondral bone erosions. TNF-alpha-blocking agents Such as infliximab have been successful in treatment of disease-modifying antirheumatic drug-resistant rheumatic diseases. Infliximab therapy in RA also had beneficial effects on local bone destruction and bone mineral density. We assessed effects of infliximab treatment on the bone tissue compartment and cytokine profile expression in vitro. Methods. Osteoblast-like cells were exposed for 24 h to sera of RA patients collected at baseline and after I month (T1) and 3 years (T2) of infliximab treatment. Total RNA was extracted, and expression of interleukin 1 beta (IL-1 beta), IL-6, and osteoprotegerin (OPG) was measured by RT-PCR. Results. IL-1 beta gene expression was significantly reduced by the T1 serum, and the same decrease was elicited by the T2 serum. IL-6 downregulation was evident with the T2 serum. OPG was unaffected. Conclusion. The finding of downregulation of inflammatory cytokines was interesting, particularly IL-6, which plays a crucial role in arthritis-related bone loss due to its involvement in osteoclast recruitment and activation. These results may represent a biological explanation and a link for the clinical observation of the beneficial effects of anti-TNF-alpha. agents on the progression of rheumatic diseases at the bone level. (First Release July 1 2009; J Rheumatol 2009;36:1575-9 doi: 10.3899/jrheum.081321)
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available